A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...

People are having to choose between the prescription drugs that they need and… food or their rent.” Consumer Investigator ...

A bipartisan legislative task force is out with new recommendations to make the cost of prescription medicine easier on the ...

With health care costs rising and obesity-related conditions impacting workplace productivity, employers are increasingly ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...